KENSEY NASH CORP (NASDAQ: KNSY)

View Portfolio
Back to Investopedia
Back to Investopedia




$20.44 0.56 (2.82%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
29.73
52-Week Low Price
15.11
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.22 B
P/E Ratio (TTM)
12.6
Diluted EPS (TTM)
1.72
Shares
11.09 M
Dividend Rate ($) / (%)
0.00/0.00
51%
49%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 3% - KNSY has underperformed the S&P 500 by 23%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
ORTHOVITA INC (VITA) $3.56 -  $0.14(4.09%)0.26 B
ATRION CORPORATION (ATRI) $133.84 -  $3.41(2.61%)0.26 B
BIOMIMETIC THERAPEUT INC (BMTI) $11.86 -  $0.32(2.77%)0.25 B
ALPHATEC HOLDINGS INC (ATEC) $4.41 -  $0.04(0.92%)0.23 B
ORASURE TECHNOLOGIES INC (OSUR) $4.85 -  $0.06(1.22%)0.23 B
ENDOLOGIX INC (ELGX) $4.26 -  $0.06(1.43%)0.21 B
EXACTECH INC (EXAC) $16.32 -  $0.39(2.45%)0.21 B
ELECTRO OPTICAL SCIENCES (MELA) $8.83 -  $0.06(0.68%)0.20 B
HOME DIAGNOSTICS INC (HDIX) $11.46 -  $0.01(0.09%)0.19 B
MEDICAL ACTION IND INC (MDCI) $11.27 -  $0.07(0.63%)0.19 B
As of February 09, 2010 at 6:45 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
KNSY RELATED HEADLINES
arrow
Kensey Nash names chief financial officer

Forbes.com 3/5/2009
arrow
BRIEF-Kensey Nash names new CFO

Forbes.com 3/5/2009
arrow
Kensey Nash wants to test knee implant in humans

Forbes.com 2/24/2009
arrow
Earnings roundup: Kensey Nash, Energen

Forbes.com 1/28/2009
arrow
Kensey Nash 2Q profit doubles

Forbes.com 1/28/2009
arrow
BRIEF-Ramius files preliminary consent solicitation statement

Forbes.com 12/10/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2